Cancer Immunology 2020
DOI: 10.1007/978-3-030-57949-4_20
|View full text |Cite
|
Sign up to set email alerts
|

Immunology and Immunotherapy of Ovarian Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 464 publications
0
1
0
Order By: Relevance
“…Most ovarian cancers are regularly known as a "silent killer" because about 75% of sufferers are identified in the superior level of the ailment because of the absence of nonspecific medical signs at the start and the dearth of screening techniques for prognosis [2]. Up until now, the gold preferred withinside the prognosis of pelvic loads continues to be a bimanual gynecological exam supplemented through transvaginal sonography (with color Doppler) and serum markers (CA125, in the end, blended with HE4 and calculated ROMA).…”
Section: Introductionmentioning
confidence: 99%
“…Most ovarian cancers are regularly known as a "silent killer" because about 75% of sufferers are identified in the superior level of the ailment because of the absence of nonspecific medical signs at the start and the dearth of screening techniques for prognosis [2]. Up until now, the gold preferred withinside the prognosis of pelvic loads continues to be a bimanual gynecological exam supplemented through transvaginal sonography (with color Doppler) and serum markers (CA125, in the end, blended with HE4 and calculated ROMA).…”
Section: Introductionmentioning
confidence: 99%